Research Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital, University of Oulu, Oulu, Finland.
Heart Center, Turku University Hospital and University of Turku, Turku, Finland.
PLoS One. 2022 Dec 28;17(12):e0279443. doi: 10.1371/journal.pone.0279443. eCollection 2022.
Smoking is the biggest preventable factor causing mortality and morbidity and the health benefits of smoking cessation are commonly known. Smoking cessation-related weight gain is well documented. We evaluated the association between smoking cessation and the incidence of obesity-related morbidities such as hypertension, diabetes and metabolic syndrome as well as mortality. We also evaluated telomere length related to smoking cessation.
This study was part of the OPERA (Oulu Project Elucidating Risk of Atherosclerosis) study. The mean follow up time among the 600 study subjects was 20 years. We divided the study subjects into four groups by smoking status ("never", "current", "ex-smokers" and "quit") and analyzed their health status. "Ex-smokers" had quit smoking before baseline and "quit" quit during the follow-up time. Information about total mortality between the years 2013-2020 was also utilized.
During the follow-up time systolic blood pressure decreased the most in the "current" and in the "ex-smoker" groups. Office SBP decreased the least in the "quit" group (p = 0.001). BMI increased the most in the "quit" and the least in the "ex-smokers" group (p = 0.001). No significant increases were seen in the incidence of obesity-related-diseases, such as metabolic syndrome, hypertension and diabetes was seen. There was no significant difference in the shortening of telomeres. Odds of short-term mortality was increased in the "current" group (2.43 (CI 95% 1.10; 5.39)), but not in the "quit" (1.43 (CI 95% 0.73-2.80)) or "ex-smoker" (1.02 (CI 95% 0.56-1.86)) groups when compared to "never" group.
Even though, the blood pressure levels were unfavorable in the "quit" group, there was no significant increase in the incidence of obesity-related-diseases, and a noticeable benefit in short-term mortality was seen during the 6-year follow-up. The benefits of smoking cessation outweigh the disadvantages in the long-term.
吸烟是导致死亡和发病的最大可预防因素,戒烟的健康益处众所周知。戒烟后体重增加是有据可查的。我们评估了戒烟与高血压、糖尿病和代谢综合征等肥胖相关疾病的发病率以及死亡率之间的关系。我们还评估了与戒烟相关的端粒长度。
本研究是 Oulu 项目阐明动脉粥样硬化风险(OPERA)研究的一部分。600 名研究对象的平均随访时间为 20 年。我们根据吸烟状况(“从不”、“当前”、“曾经”和“已戒”)将研究对象分为四组,并分析了他们的健康状况。“曾经”是指在基线前戒烟,“已戒”是指在随访期间戒烟。还利用了 2013-2020 年间的总死亡率信息。
在随访期间,“当前”和“曾经”组的收缩压下降最多。“已戒”组的诊室收缩压下降最少(p = 0.001)。BMI 增加最多见于“已戒”组,而“曾经”组增加最少(p = 0.001)。没有发现肥胖相关疾病(如代谢综合征、高血压和糖尿病)发病率显著增加。端粒缩短也没有显著差异。与“从不”组相比,“当前”组的短期死亡率风险增加(2.43(95%CI 1.10;5.39)),但“已戒”组(1.43(95%CI 0.73-2.80))和“曾经”组(1.02(95%CI 0.56-1.86))则不然。
尽管“已戒”组的血压水平不利,但肥胖相关疾病的发病率没有显著增加,而且在 6 年的随访中观察到短期死亡率有明显获益。从长期来看,戒烟的好处大于坏处。